Proactive Measures for Seasonal Health Risks As Pakistan braces for the monsoon season, the Drug Regulatory Authority of Pakistan (DRAP) has formally requested pharmaceutical companies—including the Pakistan Pharmaceutical Manufacturers Association (PPMA) and Pharma Bureau—to confirm the availability of essential medicines and raw materials needed to treat common seasonal illnesses.
Targeted Diseases and Supplies DRAP’s inquiry focuses on stock levels for treatments related to:
- Malaria
- Typhoid
- Diarrhea
- Skin infections and allergic reactions
Pharma companies have reportedly assured DRAP of sufficient inventories of anti-malarials, antibiotics, vaccines, and critical raw materials such as electrolyte drips and corticosteroids.
Industry Response and Readiness According to sources, manufacturers have confirmed that they are well-prepared to meet demand spikes during the rainy season. This includes medicines for acute infections, dermatological conditions, and gastrointestinal disorders that typically surge due to waterborne pathogens and humidity-related complications.
Conclusion: A Coordinated Effort for Public Health DRAP’s early engagement with the pharmaceutical sector reflects a strategic approach to prevent medicine shortages and ensure healthcare system resilience during the monsoon. With industry cooperation, Pakistan is better positioned to manage seasonal health risks and safeguard vulnerable populations.
+ There are no comments
Add yours